NEW YORK (GenomeWeb News) – Biospecimen firm Sanguine BioSciences announced on Thursday the closing of its seed funding round.

The round was led by Invent Ventures and Heliant Ventures and will be used to further build Sanguine's infrastructure, it said. Sanguine did not disclose the amount of the funding.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.